Cubist Systematic Strategies, LLC
Institutional investor · Portfolio as of Q3 2025
Top Holdings2,948 positions
VANECK ETF TRUST | 2.2M | $171.1M | 0.8% | — | — | — | Increased — |
SPDR GOLD TR | 463,100 | $164.6M | 0.8% | — | — | — | Increased — |
ORACLE CORP | 482,600 | $135.7M | 0.6% | — | — | — | Increased — |
ORACLE CORP | 453,800 | $127.6M | 0.6% | — | — | — | Increased — |
SPDR GOLD TR | 330,900 | $117.6M | 0.6% | — | — | — | Increased — |
UNITEDHEALTH GROUP INC | 337,000 | $116.4M | 0.6% | — | — | — | Increased — |
PALANTIR TECHNOLOGIES INC | 600,500 | $109.5M | 0.5% | — | — | — | Decreased — |
ROBINHOOD MKTS INC | 736,700 | $105.5M | 0.5% | — | — | — | Increased — |
PALANTIR TECHNOLOGIES INC | 563,000 | $102.7M | 0.5% | — | — | — | Increased — |
NEBIUS GROUP N.V. | 877,600 | $98.5M | 0.5% | — | — | — | Increased — |
BOSTON SCIENTIFIC CORP | 903,124 | $88.2M | 0.4% | $97.02 | -53.66% | 8 qtrssince 2023-Q4 | Increased 58 |
NVIDIA CORPORATION | 465,900 | $86.9M | 0.4% | — | — | — | Increased — |
ISHARES TR | 954,100 | $85.3M | 0.4% | — | — | — | Increased — |
NETFLIX INC. | 70,600 | $84.6M | 0.4% | — | — | — | Decreased — |
UNITEDHEALTH GROUP INC | 237,100 | $81.9M | 0.4% | — | — | — | Increased — |
VANECK ETF TRUST | 1M | $79.1M | 0.4% | — | — | — | Decreased — |
SELECT SECTOR SPDR TR | 875,800 | $78.2M | 0.4% | — | — | — | Increased — |
ROBINHOOD MKTS INC | 538,300 | $77.1M | 0.4% | — | — | — | Decreased — |
ROBLOX CORP | 501,500 | $69.5M | 0.3% | — | — | — | Decreased — |
AXON ENTERPRISE INC | 95,000 | $68.2M | 0.3% | — | — | — | Increased — |
Cubist Systematic Strategies, LLC manages $21B across 2948 positions as of Q3 2025. Top holdings: GDX (0.8%), GLD (0.8%), ORCL (0.6%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.
Active quarter - 617 new positions, 614 exits, 353 increased. Top move: BSX (INCREASED, conviction 58). Portfolio: $21.0B across 2948 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Last filed Q3 2025 - no longer filing.
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR